Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.37 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.37 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4951991 | 1.00 | ALDH1A1 (0.52) | ALDH1A1GAATAAR1LMNAFOLH1 | |
| SCHEMBL4952673 | 0.84 | ALDH1A1 (0.47) | ALDH1A1GAATAAR1LMNACA2 | |
| SCHEMBL4955501 | 0.84 | LMNA (0.49) | ALDH1A1GAALMNAFOLH1CA2 | |
| SCHEMBL4955497 | 0.84 | LMNA (0.49) | ALDH1A1GAALMNAFOLH1CA2 | |
| SCHEMBL4952677 | 0.84 | ALDH1A1 (0.47) | ALDH1A1GAATAAR1LMNACA2 | |
| SCHEMBL4955678 | 0.82 | ALDH1A1 (0.44) | ALDH1A1GAATAAR1L3MBTL1 | |
| SCHEMBL4955682 | 0.82 | ALDH1A1 (0.44) | ALDH1A1GAATAAR1L3MBTL1 | |
| SCHEMBL10935574 | 0.81 | ALDH1A1 (0.55) | ALDH1A1GAATAAR1LMNACA2 | |
| SCHEMBL11224138 | 0.81 | ALDH1A1 (0.55) | ALDH1A1GAATAAR1LMNACA2 | |
| SCHEMBL4951639 | 0.81 | FOLH1 (0.35) | ALDH1A1GAALMNAFOLH1NAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7465471-B2 | Palatability of aquaculture feed | NOVUS INTERNATIONAL, INC. (US) | 2008-12-16 | — | — | US | disclosed |
| WO-2007147155-A1 | POLYOL ESTER COMPOUNDS | NOVUS INTERNATIONAL INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20070292485-A1 | POLYOL ESTER COMPOUNDS | NOVUS INTERNATIONAL INC. (US) | 2007-12-20 | — | — | US | disclosed |
| US-20050215623-A1 | Palatability of aquaculture feed | NOVUS INTERNATIONAL, INC. (US) | 2005-09-29 | — | — | US | disclosed |
| US-20040175434-A1 | Antimicrobial compositions | NOVUS INTERNATIONAL, INC. | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292485-A1 | POLYOL ESTER COMPOUNDS | PNLIP, ELOVL1, ELOVL5 | ALDH1A1 679/4885GAA 319/4885TAAR1 4012/4885 |
| US-20050215623-A1 | Palatability of aquaculture feed | TAS2R3, TAS2R1, TAS2R20 | ALDH1A1 585/4885GAA 1395/4885TAAR1 1097/4885 |
| US-20040175434-A1 | Antimicrobial compositions | MRPL21, FPR1, ARG1 | ALDH1A1 2079/4885GAA 2335/4885TAAR1 3995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.